The effects of penbutolol 20-30 mg twice daily and of metoprolol 50-150 mg three times daily were studied in five and nine patients, respectively, with moderate hypertension. Both drugs significantly reduced blood pressure and pulse rate under basal conditions and in connection with exercise. Plasma catecholamine levels were not altered in supine or upright position, neither during penbutolol nor during metoprolol treatment. Following work there was an enhanced response in both plasma noradrenaline and adrenaline during penbutolol but only in plasma noradrenaline during metoprolol treatment. Both drugs effectively reduced basal plasma renin activity but only penbutolol abolished the renin response to work. Penbutolol significantly reduced urinary aldosterone excretion whereas metoprolol caused no significant changes. Neither penbutolol nor metoprolol affected maximal working capacity.

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/4.suppl_d.57DOI Listing

Publication Analysis

Top Keywords

penbutolol metoprolol
12
effects penbutolol
8
blood pressure
8
renin activity
8
metoprolol treatment
8
plasma noradrenaline
8
metoprolol
6
penbutolol
6
plasma
5
metoprolol blood
4

Similar Publications

A highly sensitive method using ultra-fast liquid chromatography coupled with quadrupole/linear ion trap mass spectrometry (UFLC-Q/Trap MS) was developed to simultaneously screen and confirm nine beta-blockers (BBs) in porcine tissues (porcine muscle, liver and kidney). The method was used for trace determination of atenolol, pindolol, acebutolol, metoprolol, carazolol, labetalol, bisoprolol, propranolol and penbutolol. The homogenized tissues were hydrolyzed by beta-glucuronidase/aryl sulfatase and extracted with acetonitrile, followed by continuous purification procedures of disperse solid phase extraction (d-SPE) with diatomaceous earth and BondElut cartridge.

View Article and Find Full Text PDF

A liquid chromatographic-mass spectrometric assay with atmospheric pressure chemical ionization (LC-APCI-MS) is presented for screening for, library-assisted identification (both in scan mode) and quantification (selected-ion mode) of the beta-blockers acebutolol, diacetolol, alprenolol, atenolol, betaxolol, bisoprolol, bupranolol, carazolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, metoprolol, nadolol, nebivolol, oxprenolol, penbutolol, propranolol, sotalol, talinolol and timolol in blood plasma after mixed-mode (HCX) solid-phase extraction (SPE) and separation by reverse-phase liquid chromatography with gradient elution. The validation data were within the required limits. The assay was successfully applied to authentic plasma samples allowing confirmation of diagnosis of overdose situations as well as monitoring of patients' compliance.

View Article and Find Full Text PDF

Introduction: Beta blockers are of great importance in the treatment of arterial hypertension, coronary heart disease, cardiac arrhythmias and heart failure. Their effects are mediated by the blockade of various alpha- und beta-receptors and specific com-pounds have been developed to address them.

Pharmacology: Nonselective beta blockers (e.

View Article and Find Full Text PDF

Urine specimens containing 11 common beta blockers were processed using solid-phase extraction technology to extract the drugs from the urine matrix, then converted to their cyclic methaneboronates by treatment with methaneboronic acid in ethyl acetate. The compounds tested included acebutolol, atenolol, alprenolol, bisoprolol, betaxolol, carteolol, penbutolol, propranolol, pindolol, timolol, nadolol, sotalol, labetolol, metoprolol, and oxprenolol. The extraction efficiencies were greater than 90% for all drugs tested.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!